Manalang, Jezamie A.

HRN: 28-93-94  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2026
CEFTRIAXONE 1G (VIAL)
05/05/2026
05/12/2026
IV
2g
OD
TBI, Moderate
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: